Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
China
· Delayed Price · Currency is CNY 58.21
+0.01 (0.02%)
Apr 29, 2026, 3:00 PM CST
SHA:688799 Revenue
Hunan Warrant Pharmaceutical Co.,Ltd had revenue of 324.55M CNY in the quarter ending March 31, 2026, a decrease of -3.48%. This brings the company's revenue in the last twelve months to 1.49B, up 8.45% year-over-year. In the year 2025, Hunan Warrant Pharmaceutical Co.,Ltd had annual revenue of 1.50B with 6.46% growth.
Revenue (ttm)
1.49B
Revenue Growth
+8.45%
P/S Ratio
5.08
Revenue / Employee
n/a
Employees
1,234
Market Cap
7.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.50B | 91.28M | 6.46% |
| Dec 31, 2024 | 1.41B | -19.84M | -1.38% |
| Dec 31, 2023 | 1.43B | 140.13M | 10.84% |
| Dec 31, 2022 | 1.29B | 146.06M | 12.74% |
| Dec 31, 2021 | 1.15B | 195.97M | 20.61% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Animal Husbandry Industry | 6.20B |
| Guangxi Wuzhou Zhongheng Group | 1.75B |
| Renhe Pharmacy Co.,Ltd | 3.54B |
| KPC Pharmaceuticals,Inc. | 5.80B |
| Jiangsu Kanion Pharmaceutical | 3.29B |
| Tianjin Ringpu Bio-Technology | 3.40B |
| Changchun BCHT Biotechnology Co. | 590.13M |
| Guilin Sanjin Pharmaceutical | 2.08B |